Attached files
Exhibit
32
Certification of CEO and CFO Pursuant to
18 U.S.C. Section 1350,
As Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
18 U.S.C. Section 1350,
As Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
In connection with
the Annual Report of Regeneron Pharmaceuticals, Inc. (the "Company") on Form
10-K for the year ended December 31, 2009 as filed with the Securities and
Exchange Commission on the date hereof (the "Report"), Leonard S. Schleifer,
M.D., Ph.D., as Chief Executive Officer of the Company, and Murray A. Goldberg,
as Chief Financial Officer of the Company, each hereby certifies, pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, to the best of his knowledge, that:
(1) The Report fully
complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and
(2) The information
contained in the Report fairly presents, in all material respects, the financial
condition and result of operations of the Company.
| /s/ LEONARD S. SCHLEIFER | |
| Leonard S. Schleifer, M.D., Ph.D. | |
| Chief Executive Officer | |
| February 18, 2010 | |
| /s/ MURRAY A. GOLDBERG | |
| Murray A. Goldberg | |
| Chief Financial Officer | |
| February 18, 2010 |